|
DNX-2401 Clinical Trials
2 actively recruiting trials across 1 location
▲ +1 trial since May 2026
Pipeline
Phase 2: 2
Top Sponsors
- University of California, San Francisco1
- Clinica Universidad de Navarra, Universidad de Navarra1
Indications
- Cancer2
- Embryonal Tumor of Brain1
- Recurrent WHO Grade III Glioma1
- Recurrent Diffuse Midline Glioma, H3 K27M-Mutant1
- Recurrent Diffuse Intrinsic Pontine Glioma1
Other1 trial
Birmingham, Alabama1 trial
Combination Therapy for the Treatment of Diffuse Midline Gliomas
University of Alabama at Birmingham
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.